AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-35654320_ITM" title="Facts and information about Inverness Medical's ratings on review for possible downgrade - Moody's.">Inverness Medical's ratings on review for possible downgrade - Moody's.</a>
Close
Set up an RSS feed that alerts you when new articles from Europe Intelligence Wire are available.
Frequently asked questions about RSS feeds
Inverness Medical's ratings on review for possible downgrade - Moody's.
(From AFX UK (Focus))
MUMBAI (Thomson Financial) - Moody's Investors Service placed the ratings of Inverness Medical Innovations Inc on review for possible downgrade after the company agreed to buy the remaining 95.3 pct of Biosite Inc for 90 usd a share.
The ratings include Inverness' B2 corporate family rating, B2 probability of default rating and Caa1 rating on 150 mln usd of senior subordinated notes due 2012.
The review …
Related articles from newspapers, magazines, journals, and more
-
- Trinity Biotech settles dispute with Inverness Medical.
-
News wire article from: Europe Intelligence Wire
August 8, 2006
700+ words
-
- BBI secures 7.5 mln stg financing from Inverness Medical to accelerate growth.
-
News wire article from: Europe Intelligence Wire
October 17, 2006
700+ words
-
- AFX NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 15:40 BST.
-
News wire article from: Europe Intelligence Wire
August 21, 2006
700+ words
-
- AFX UK at a glance share guide.
-
News wire article from: Europe Intelligence Wire
March 6, 2007
700+ words
